AGE1

AGE1 is an accelerator for longevity companies. Longevity is at an inflection point: due to scientific advances over the last 30 years, we are beginning to change how we interact with chronological age, living a longer number of healthy years than ever before. Here and now, we embark on this journey. Age1 is a 4-month program based in SF which offers both capital and help to launch founder-driven biotechnology companies. We are selecting a small group of innovative scientists and technologists who are working to extend human healthspan to bring to San Francisco. We invest in them and their ideas, connect them with the best mentors and advisors, and help them reach critical inflection points faster. AGE1 is backed and advised by The Longevity Fund, Laura Deming, Felicis Ventures, Marc Andreessen, Elad Gil, and Founders Fund.